FDA Accepts for Review INOVIO’s BLA for INO-3107 for the Treatment of Adults with Recurrent Respiratory Papillomatosis (RRP)
Dr. J. Joseph Kim
© Copyright 2026 INOVIO Pharmaceuticals. All rights reserved.
